1999
AUTHORSGwan Gyu Song , Martin Fleck , Jianguo Wu , Hui-Chen Hsu , Tong Zhou , John D. Mountz
ABSTRACTThe pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE. More... »
PAGES181-212
Apoptosis and Inflammation
ISBN
978-3-0348-9752-5
978-3-0348-8741-0
http://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11
DOIhttp://dx.doi.org/10.1007/978-3-0348-8741-0_11
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1017221860
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biochemistry and Cell Biology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Immunology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea",
"id": "http://www.grid.ac/institutes/grid.222754.4",
"name": [
"Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea"
],
"type": "Organization"
},
"familyName": "Song",
"givenName": "Gwan Gyu",
"id": "sg:person.01237240713.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237240713.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Fleck",
"givenName": "Martin",
"id": "sg:person.0732712231.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732712231.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA",
"id": "http://www.grid.ac/institutes/grid.265892.2",
"name": [
"Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
],
"type": "Organization"
},
"familyName": "Wu",
"givenName": "Jianguo",
"id": "sg:person.015250132354.22",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015250132354.22"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA",
"id": "http://www.grid.ac/institutes/grid.265892.2",
"name": [
"Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
],
"type": "Organization"
},
"familyName": "Hsu",
"givenName": "Hui-Chen",
"id": "sg:person.01263522210.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA",
"id": "http://www.grid.ac/institutes/grid.265892.2",
"name": [
"Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
],
"type": "Organization"
},
"familyName": "Zhou",
"givenName": "Tong",
"id": "sg:person.0664616100.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA",
"id": "http://www.grid.ac/institutes/grid.280808.a",
"name": [
"Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA",
"Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA"
],
"type": "Organization"
},
"familyName": "Mountz",
"givenName": "John D.",
"id": "sg:person.07550405624.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18"
],
"type": "Person"
}
],
"datePublished": "1999",
"datePublishedReg": "1999-01-01",
"description": "The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE.",
"editor": [
{
"familyName": "Winkler",
"givenName": "James D.",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-0348-8741-0_11",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-0348-9752-5",
"978-3-0348-8741-0"
],
"name": "Apoptosis and Inflammation",
"type": "Book"
},
"keywords": [
"systemic lupus erythematosus",
"lupus-like syndrome",
"death receptor 3",
"death domain",
"death domain family",
"inflammatory cells",
"domain family",
"human autoimmune diseases",
"tumor necrosis factor receptor 1",
"apoptosis defects",
"transmembrane exon",
"necrosis factor receptor 1",
"Fas apoptosis",
"modulate apoptosis",
"cellular defects",
"domain molecules",
"factor receptor 1",
"SLE patients",
"lupus erythematosus",
"autoreactive cells",
"cell hyperactivity",
"chronic inflammation",
"autoimmune diseases",
"family molecules",
"inflammatory response",
"clonal deletion",
"cell dysfunction",
"apoptosis",
"hormonal factors",
"Fas ligand",
"molecular mimicry",
"patients",
"receptor 3",
"receptor 1",
"syndrome disease",
"converting enzyme",
"lupus",
"primary pathway",
"soluble form",
"soluble inhibitor",
"environmental factors",
"pathway",
"syndrome",
"cells",
"FA",
"disease",
"environment triggers",
"ligand 2",
"exons",
"molecules",
"domain",
"protein",
"deletion",
"mutations",
"erythematosus",
"inflammation",
"enzyme",
"dysfunction",
"pathogenesis",
"mimicry",
"defects",
"hyperactivity",
"DR4",
"clearance",
"factors",
"family",
"inhibitors",
"failure",
"ligands",
"response",
"triggers",
"levels",
"elimination",
"loss",
"form",
"focus",
"chapter",
"DRS"
],
"name": "Lupus and lupus-like syndromes",
"pagination": "181-212",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1017221860"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-0348-8741-0_11"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-0348-8741-0_11",
"https://app.dimensions.ai/details/publication/pub.1017221860"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-20T07:42",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_162.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-0348-8741-0_11"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'
This table displays all metadata directly associated to this object as RDF triples.
191 TRIPLES
23 PREDICATES
105 URIs
96 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-0348-8741-0_11 | schema:about | anzsrc-for:06 |
2 | ″ | ″ | anzsrc-for:0601 |
3 | ″ | ″ | anzsrc-for:11 |
4 | ″ | ″ | anzsrc-for:1107 |
5 | ″ | schema:author | Ndfcc242fabfc4bf1a495243fff7d1b58 |
6 | ″ | schema:datePublished | 1999 |
7 | ″ | schema:datePublishedReg | 1999-01-01 |
8 | ″ | schema:description | The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE. |
9 | ″ | schema:editor | N8200e5da55d345deacd34f73a87d69fd |
10 | ″ | schema:genre | chapter |
11 | ″ | schema:inLanguage | en |
12 | ″ | schema:isAccessibleForFree | false |
13 | ″ | schema:isPartOf | N7fed9264d9454cadbc2138ead85050e0 |
14 | ″ | schema:keywords | DR4 |
15 | ″ | ″ | DRS |
16 | ″ | ″ | FA |
17 | ″ | ″ | Fas apoptosis |
18 | ″ | ″ | Fas ligand |
19 | ″ | ″ | SLE patients |
20 | ″ | ″ | apoptosis |
21 | ″ | ″ | apoptosis defects |
22 | ″ | ″ | autoimmune diseases |
23 | ″ | ″ | autoreactive cells |
24 | ″ | ″ | cell dysfunction |
25 | ″ | ″ | cell hyperactivity |
26 | ″ | ″ | cells |
27 | ″ | ″ | cellular defects |
28 | ″ | ″ | chapter |
29 | ″ | ″ | chronic inflammation |
30 | ″ | ″ | clearance |
31 | ″ | ″ | clonal deletion |
32 | ″ | ″ | converting enzyme |
33 | ″ | ″ | death domain |
34 | ″ | ″ | death domain family |
35 | ″ | ″ | death receptor 3 |
36 | ″ | ″ | defects |
37 | ″ | ″ | deletion |
38 | ″ | ″ | disease |
39 | ″ | ″ | domain |
40 | ″ | ″ | domain family |
41 | ″ | ″ | domain molecules |
42 | ″ | ″ | dysfunction |
43 | ″ | ″ | elimination |
44 | ″ | ″ | environment triggers |
45 | ″ | ″ | environmental factors |
46 | ″ | ″ | enzyme |
47 | ″ | ″ | erythematosus |
48 | ″ | ″ | exons |
49 | ″ | ″ | factor receptor 1 |
50 | ″ | ″ | factors |
51 | ″ | ″ | failure |
52 | ″ | ″ | family |
53 | ″ | ″ | family molecules |
54 | ″ | ″ | focus |
55 | ″ | ″ | form |
56 | ″ | ″ | hormonal factors |
57 | ″ | ″ | human autoimmune diseases |
58 | ″ | ″ | hyperactivity |
59 | ″ | ″ | inflammation |
60 | ″ | ″ | inflammatory cells |
61 | ″ | ″ | inflammatory response |
62 | ″ | ″ | inhibitors |
63 | ″ | ″ | levels |
64 | ″ | ″ | ligand 2 |
65 | ″ | ″ | ligands |
66 | ″ | ″ | loss |
67 | ″ | ″ | lupus |
68 | ″ | ″ | lupus erythematosus |
69 | ″ | ″ | lupus-like syndrome |
70 | ″ | ″ | mimicry |
71 | ″ | ″ | modulate apoptosis |
72 | ″ | ″ | molecular mimicry |
73 | ″ | ″ | molecules |
74 | ″ | ″ | mutations |
75 | ″ | ″ | necrosis factor receptor 1 |
76 | ″ | ″ | pathogenesis |
77 | ″ | ″ | pathway |
78 | ″ | ″ | patients |
79 | ″ | ″ | primary pathway |
80 | ″ | ″ | protein |
81 | ″ | ″ | receptor 1 |
82 | ″ | ″ | receptor 3 |
83 | ″ | ″ | response |
84 | ″ | ″ | soluble form |
85 | ″ | ″ | soluble inhibitor |
86 | ″ | ″ | syndrome |
87 | ″ | ″ | syndrome disease |
88 | ″ | ″ | systemic lupus erythematosus |
89 | ″ | ″ | transmembrane exon |
90 | ″ | ″ | triggers |
91 | ″ | ″ | tumor necrosis factor receptor 1 |
92 | ″ | schema:name | Lupus and lupus-like syndromes |
93 | ″ | schema:pagination | 181-212 |
94 | ″ | schema:productId | N9a75f6ce90f44d6cbb10056a95371434 |
95 | ″ | ″ | Ncc5c877b8cf54a31a5c6913e0c1a8f9d |
96 | ″ | schema:publisher | N782c66c1ca024b04adc8b8de9c117ca0 |
97 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1017221860 |
98 | ″ | ″ | https://doi.org/10.1007/978-3-0348-8741-0_11 |
99 | ″ | schema:sdDatePublished | 2022-05-20T07:42 |
100 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
101 | ″ | schema:sdPublisher | N844561d0c1ac44a59ca951befe60976c |
102 | ″ | schema:url | https://doi.org/10.1007/978-3-0348-8741-0_11 |
103 | ″ | sgo:license | sg:explorer/license/ |
104 | ″ | sgo:sdDataset | chapters |
105 | ″ | rdf:type | schema:Chapter |
106 | N1781491eed164c91a168f396507c3e36 | schema:familyName | Winkler |
107 | ″ | schema:givenName | James D. |
108 | ″ | rdf:type | schema:Person |
109 | N3028101870b0409cb5d54281c6c47dc3 | rdf:first | sg:person.01263522210.53 |
110 | ″ | rdf:rest | Ncb77fbb64c2a4169b511c8f3659039ab |
111 | N782c66c1ca024b04adc8b8de9c117ca0 | schema:name | Springer Nature |
112 | ″ | rdf:type | schema:Organisation |
113 | N7fed9264d9454cadbc2138ead85050e0 | schema:isbn | 978-3-0348-8741-0 |
114 | ″ | ″ | 978-3-0348-9752-5 |
115 | ″ | schema:name | Apoptosis and Inflammation |
116 | ″ | rdf:type | schema:Book |
117 | N8200e5da55d345deacd34f73a87d69fd | rdf:first | N1781491eed164c91a168f396507c3e36 |
118 | ″ | rdf:rest | rdf:nil |
119 | N844561d0c1ac44a59ca951befe60976c | schema:name | Springer Nature - SN SciGraph project |
120 | ″ | rdf:type | schema:Organization |
121 | N9a75f6ce90f44d6cbb10056a95371434 | schema:name | doi |
122 | ″ | schema:value | 10.1007/978-3-0348-8741-0_11 |
123 | ″ | rdf:type | schema:PropertyValue |
124 | Nbc7dfa334a1f4fdeaf25a863504efee8 | rdf:first | sg:person.0732712231.14 |
125 | ″ | rdf:rest | Nfe93cd114dab4373a79134de1d3e81d2 |
126 | Nc9a9d141365e4c2fad57be41483403a8 | rdf:first | sg:person.07550405624.18 |
127 | ″ | rdf:rest | rdf:nil |
128 | Ncb77fbb64c2a4169b511c8f3659039ab | rdf:first | sg:person.0664616100.38 |
129 | ″ | rdf:rest | Nc9a9d141365e4c2fad57be41483403a8 |
130 | Ncc5c877b8cf54a31a5c6913e0c1a8f9d | schema:name | dimensions_id |
131 | ″ | schema:value | pub.1017221860 |
132 | ″ | rdf:type | schema:PropertyValue |
133 | Ndfcc242fabfc4bf1a495243fff7d1b58 | rdf:first | sg:person.01237240713.10 |
134 | ″ | rdf:rest | Nbc7dfa334a1f4fdeaf25a863504efee8 |
135 | Nfe93cd114dab4373a79134de1d3e81d2 | rdf:first | sg:person.015250132354.22 |
136 | ″ | rdf:rest | N3028101870b0409cb5d54281c6c47dc3 |
137 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
138 | ″ | schema:name | Biological Sciences |
139 | ″ | rdf:type | schema:DefinedTerm |
140 | anzsrc-for:0601 | schema:inDefinedTermSet | anzsrc-for: |
141 | ″ | schema:name | Biochemistry and Cell Biology |
142 | ″ | rdf:type | schema:DefinedTerm |
143 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
144 | ″ | schema:name | Medical and Health Sciences |
145 | ″ | rdf:type | schema:DefinedTerm |
146 | anzsrc-for:1107 | schema:inDefinedTermSet | anzsrc-for: |
147 | ″ | schema:name | Immunology |
148 | ″ | rdf:type | schema:DefinedTerm |
149 | sg:person.01237240713.10 | schema:affiliation | grid-institutes:grid.222754.4 |
150 | ″ | schema:familyName | Song |
151 | ″ | schema:givenName | Gwan Gyu |
152 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237240713.10 |
153 | ″ | rdf:type | schema:Person |
154 | sg:person.01263522210.53 | schema:affiliation | grid-institutes:grid.265892.2 |
155 | ″ | schema:familyName | Hsu |
156 | ″ | schema:givenName | Hui-Chen |
157 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53 |
158 | ″ | rdf:type | schema:Person |
159 | sg:person.015250132354.22 | schema:affiliation | grid-institutes:grid.265892.2 |
160 | ″ | schema:familyName | Wu |
161 | ″ | schema:givenName | Jianguo |
162 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015250132354.22 |
163 | ″ | rdf:type | schema:Person |
164 | sg:person.0664616100.38 | schema:affiliation | grid-institutes:grid.265892.2 |
165 | ″ | schema:familyName | Zhou |
166 | ″ | schema:givenName | Tong |
167 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38 |
168 | ″ | rdf:type | schema:Person |
169 | sg:person.0732712231.14 | schema:affiliation | grid-institutes:grid.7727.5 |
170 | ″ | schema:familyName | Fleck |
171 | ″ | schema:givenName | Martin |
172 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732712231.14 |
173 | ″ | rdf:type | schema:Person |
174 | sg:person.07550405624.18 | schema:affiliation | grid-institutes:grid.280808.a |
175 | ″ | schema:familyName | Mountz |
176 | ″ | schema:givenName | John D. |
177 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18 |
178 | ″ | rdf:type | schema:Person |
179 | grid-institutes:grid.222754.4 | schema:alternateName | Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea |
180 | ″ | schema:name | Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea |
181 | ″ | rdf:type | schema:Organization |
182 | grid-institutes:grid.265892.2 | schema:alternateName | Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA |
183 | ″ | schema:name | Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA |
184 | ″ | rdf:type | schema:Organization |
185 | grid-institutes:grid.280808.a | schema:alternateName | Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA |
186 | ″ | schema:name | Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA |
187 | ″ | ″ | Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA |
188 | ″ | rdf:type | schema:Organization |
189 | grid-institutes:grid.7727.5 | schema:alternateName | Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany |
190 | ″ | schema:name | Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany |
191 | ″ | rdf:type | schema:Organization |